Los Angeles Capital Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-25,398
| Closed | -$377K | – | 1230 |
|
|
2024
Q2 | $377K | Sell |
25,398
-4,000
| -14% | -$59.4K | ﹤0.01% | 939 |
|
|
2024
Q1 | $401K | Buy |
+29,398
| New | +$401K | ﹤0.01% | 932 |
|
|
2023
Q4 | – | Sell |
-105,554
| Closed | -$1.16M | – | 1183 |
|
|
2023
Q3 | $1.16M | Sell |
105,554
-4,468
| -4% | -$48.9K | ﹤0.01% | 593 |
|
|
2023
Q2 | $1.46M | Buy |
110,022
+2,800
| +3% | +$37.1K | 0.01% | 560 |
|
|
2023
Q1 | $1.46M | Buy |
107,222
+19,024
| +22% | +$259K | 0.01% | 564 |
|
|
2022
Q4 | $1.72M | Buy |
88,198
+372
| +0.4% | +$7.27K | 0.01% | 554 |
|
|
2022
Q3 | $1.67M | Sell |
87,826
-36,971
| -30% | -$704K | 0.01% | 547 |
|
|
2022
Q2 | $2.57M | Buy |
124,797
+92,192
| +283% | +$1.9M | 0.01% | 473 |
|
|
2022
Q1 | $1.05M | Buy |
+32,605
| New | +$1.05M | ﹤0.01% | 735 |
|